AI drives transformation, risk and investment across European business and finance

artificial intelligence AI governance cyber risk AI adoption AI‑driven finance

Flex Applications introduced a proactive AI‑driven HR app that automates routine tasks and offers real‑time suggestions for time‑reporting, leave requests and expense claims, emphasizing European data‑privacy compliance.

Swedish tax authorities are debating new rules that would require the agency to disclose the algorithms used to select and audit small‑business taxpayers, aiming to prevent opaque AI‑based decisions and potential profiling.

The International Monetary Fund warned that AI‑enabled cyber‑attacks could threaten global financial stability, as automated tools lower the barrier for sophisticated attacks on shared payment and banking infrastructures.

TP Vision reported that its Enginio platform, now used in 22 European markets, streamlines customer activations for Philips TVs and sound products, reducing administrative effort and improving direct consumer engagement.

A survey of the Swedish real‑estate sector showed that 60 % of organisations already use AI for tasks such as text processing, financial administration and automated property management, with most expecting efficiency gains within a year.

Thomson Reuters’ “Future of Professionals 2026” found a widening gap between client expectations for AI‑enhanced services and firms’ delivery, projecting up to $143 billion of U.S. revenue at risk and a potential 24 % talent exodus if firms do not close the gap.

Programmers in Sweden and elsewhere report anxiety as new AI coding tools appear quarterly, describing a “panic” of having to continuously up‑skill to keep pace with rapidly evolving models.

Researchers at Imperial College London and ETH Zürich unveiled a brain‑inspired spiking‑neural‑network architecture that achieves five‑fold energy efficiency and faster computation, promising greener AI workloads.

Biotech firm Attana announced a capital raise to commercialise its AI‑powered platform that selects drug candidates more reliably, aiming to cut costly late‑stage failures in pharmaceutical development.